Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 200
- Locations
- 2
- Primary Endpoint
- Hemoglobin A1C at 6 months
Study Overview
Brief Summary
The investigators propose an innovative, ED-based mHealth intervention: TExT-MED (Trial to Examine Text-Based mHealth for Emergency department patients with Diabetes). TExT-MED is a technologically simple solution using unidirectional daily text messages to consisting of educational materials, trivia questions and challenges promoting healthy lifestyle choices and reminders to check blood sugar, take medications and go to clinic appointments. The investigators believe TExT-MED will improve health outcomes including blood glucose control and encourage weight loss, healthy eating and exercise. TExT-MED is low cost, easy to use and can be quickly adapted to other practice environments.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •≥18 years old 2) have Type 2 diabetes 3) have a text message capable mobile phone 4) know how to receive text messages 5) speak and read English or Spanish and 6) have a HbA1C ≥8%.
Exclusion Criteria
- •overt psychosis 2) unable to provide informed consent and 3) pregnancy.
Outcomes
Primary Outcomes
Hemoglobin A1C at 6 months
Time Frame: 6 months
Secondary Outcomes
- DIet/ Weight Loss(6 months)
- Diabetes self-efficacy/empowerment(6 months)
- Diabetes knowledge(6 months)
Investigators
Sanjay Arora
PI
University of Southern California
